Antitumor activity of NVP-AUY922, a novel heat shock protein 90 inhibitor, in human gastric cancer cells is mediated through proteasomal degradation of client proteins
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-07-10
著者
-
Oh Do-youn
Department Of Internal Medicine Seoul National University Hospital
-
Han Sae-won
Department Of Internal Medicine Seoul National University Hospital
-
Kim Tae-you
Department Of Internal Medicine Seoul National University Hospital
-
Kim Tae-you
Department Of Internal Medicine Seoul National University College Of Medicine
-
Bang Yung-jue
Department Of Internal Medicine Seoul National University Hospital
-
Bang Yung-jue
Department Of Internal Medicine Seoul National University College Of Medicine
-
Lee Keun-wook
Seoul National University Bundang Hospital
-
Lee Kyung
Yeungnam University College Of Medicine
-
Im Seock-ah
Department Of Internal Medicine Seoul National University Hospital
-
LEE Kyung-Hun
Department of Internal Medicine, Seoul National University Hospital
-
LEE Ju-Hee
Cancer Research Institute, Seoul National University College of Medicine
-
Lee Ju-hee
Cancer Research Institute Seoul National University College Of Medicine
関連論文
- A Multicenter Retrospective Analysis of Adverse Events in Korean Patients Using Bortezomib for Multiple Myeloma
- Epidermal growth factor receptor intron 1 CA dinucleotide repeat polymorphism and survival of advanced gastric cancer patients treated with cetuximab plus modified FOLFOX6
- Hepatitis B Virus Infection and B-Cell Non-Hodgkin's Lymphoma in a Hepatitis B Endemic Area: A Case-control Study
- Antitumor activity of NVP-AUY922, a novel heat shock protein 90 inhibitor, in human gastric cancer cells is mediated through proteasomal degradation of client proteins
- Predictive value of FDG PET/CT for pathologic axillary node involvement after neoadjuvant chemotherapy